CD34 and acute myeloid leukemia: FLT3-ITD mutations are present in CD34+38− leukemic initiating cells (38) and confer an engraftment advantage over non-FLT3-ITD AML in a xenograft model (179), suggesting that ITD mutations are present in the LSC.